Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]: A Review of its Use as an Active Immunization Against Influenza A Subtype H5N1 Virus

By Carter Natalie J.   Plosker Greg L.  

BioDrugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 279-292

Adis International

Access to resources Recommend Favorite

New Strategies for the Development of H5N1 Subtype Influenza Vaccines: Progress and Challenges

By Steel John  

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 285-298

Adis International

Access to resources Recommend Favorite

Efficacy of influenza vaccine in the elderly: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic for the elderly in nursing homes

By Deguchi Y.  

International Journal of Clinical & Laboratory Research, Vol. 30, Iss. 1, 2000-03 ,pp. : 1-4

Springer Publishing Company

Access to resources Recommend Favorite

Tdap 5 Vaccine (Covaxis®): A Review of its Use as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and Pertussis in Children (Aged ≥4 Years), Adolescents, and Adults

By Scott Lesley J.  

BioDrugs, Vol. 24, Iss. 6, 2010-12 ,pp. : 387-406

Adis International

Access to resources Recommend Favorite

Adjuvanted Influenza Vaccine

By Dooley M.   Goa K.L.  

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 61-69

Adis International

Access to resources Recommend Favorite